- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Don't stampede into cash at this stage.
The media are in the entertainment business, not the professional advice business.
I object to the idea that certain stocks are the ticket to riches.
While everyone was watching Herbalife, Kate Stalter was watching Hertz and Avis earnings.
This Editor's Choice piece discusses Retalix, Ancestry.com and Tangoe.
Alexion Pharmaceuticals and Intuitive Surgical are leaders in a top-performing sector.
These small financial names recently debuted with good moving average support.
Temporary staffing, Web-based training, and consulting and research firms benefit from the no-hiring trend.
U.S. futures are pointed to a higher open after Tuesday's broad selloff.
Futures are headed lower ahead of a much-anticipated meeting between Sarkozy and Merkel.